SEC Tracker
Get the app

Regeneron Pharmaceuticals REGN

Michael S Brown (Director) sold 1,929 REGN at $875.00, worth $1.7M, under a 10b5-1 plan

Form
4
Filed
Importance
Routine
  1. 1,929 shares sold at $875
  2. 1,929 shares acquired at $725.89
  3. 5,000 shares held in trust
  4. 6,485 shares held indirectly

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Regeneron Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Alnylam Pharmaceuticals ALNY public float $42.6B, Jun 30, 2025
  2. INSMED INSM public float $21.1B, Jun 30, 2025
  3. Teva Pharmaceutical Industries TEVA public float $18.2B, Jun 30, 2025
  4. Bristol Myers Squibb BMY public float $94.2B, Jun 30, 2025
  5. United Therapeutics UTHR public float $11.2B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.